These effects, together with a past report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 help the idea of targeting ACKR3 as a novel strategy to modulate the opioid procedure, which could open new therapeutic avenues for opioid-connected disorders. Disclaimer: The above is usually a https://nicolauss271efj8.blogpixi.com/profile